Personal Genome Diagnostics, a Baltimore company that analyzes cancer patients’ genes to improve treatment and diagnosis, has received a $21.4 million venture capital investment led by New Enterprise Associates.
The company plans to use the money to sell more of its technology to sequence and analyze genes in biopsy samples.
{iframe}http://www.baltimoresun.com/business/bs-bz-personal-genome-20151028-story.html{/iframe}